Humacyte Share Price
NASDAQ: HUMA | Micro Cap | HealthcareHumacyte Stock Performance
Humacyte Share Price Today
As of 19 November 2026, Humacyte, Inc.'s share price is $0.49. The stock opened at $0.52, compared to its previous close of $0.50. During today's trading session, Humacyte, Inc.'s share price traded between $0.49 and $0.52, with an average price of $0.51. Over the past 52 weeks, the stock has recorded a high of $1.52 and a low of $0.34. In terms of performance, Humacyte, Inc.'s share price has declined by 62.02% over the last six months and is down 63.56% on a year-on-year basis.
Humacyte Share Price Chart
Humacyte Quarterly Profit & Loss
All figures in USD
Humacyte Annual Profit & Loss
All figures in USD
Humacyte Balance Sheet
All figures in USD Million
Humacyte Cash Flow
All figures in USD Million
About Humacyte
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Humacyte Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.42 | $0.50 | +21.57% |
Oct 2026 | $0.52 | $0.41 | -20.78% |
Sep 2026 | $0.60 | $0.52 | -25.90% |
Aug 2026 | $0.66 | $0.69 | +6.43% |
Jul 2026 | $0.77 | $0.65 | -16.50% |
Jun 2026 | $1.29 | $0.78 | -39.85% |
May 2026 | $0.82 | $1.30 | +54.03% |
Apr 2026 | $0.62 | $0.84 | +39.74% |
Mar 2026 | $1.07 | $0.60 | -45.59% |
Feb 2026 | $0.98 | $1.11 | +11.45% |
Jan 2026 | $0.98 | $1.00 | +3.75% |
Dec 2025 | $1.33 | $0.96 | -29.15% |